siRNA, Anti-ATG12, 2'-F/2'-OMe/LNA/Ribo/Backbone-modified(CAT#: SIRGT26813WQ-2OMe)

The product SIRGT26813WQ-2OMe is a type of small interfering RNA (siRNA) that targets ATG12 gene and regulates the expression of gene. The siRNA interferes with the expression of ATG12 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001277783.1; NM_004707.3
Alternative Names APG12; APG12L; FBR93; HAPG12
Related Diseases Stomatitis, Acute Laryngopharyngitis
Purification HPLC
Target Gene
Gene ID 9140
Uniprot ID O94817
Sub Cat Target Species Modification Scale  
SIRGT27813WQ-2F ATG12 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT29813WQ-LNA ATG12 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT26813WQ-RB ATG12 Human Ribo-modified Inquiry
SIRGT27813WQ-BB ATG12 Human Backbone-modified Inquiry

Related Products